The "Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market" report has been added to Research and Markets' offering. This analysis includes a discussion of products, competitors, ...

The advantages of Thermobalancing therapy with Dr Allen's Devices, a new revolutionary medical technology for benign prostatic hyperplasia (BPH), kidney stones and other health conditions, have been ...

Extracorporeal shock wave therapy (ESWT), a non-invasive modality, shows early promise for type IIIB chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).

A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored. Devon Tyso, a Product Design and Technology student, has ...

Clinical studies of Dr Allen’s US Patented Thermobalancing Therapy in men with benign prostatic hyperplasia or benign prostatic enlargement (BPE or BPH) have demonstrated the efficacy and safety of ...

ProUroCare Medical, Inc., of Minneapolis, Minn., has filed a de novo application with the FDA seeking marketing clearance for its prostate mechanical imaging (PMI) device (ProUroScan). This will allow ...

Charlotte, N.C.-based SonaCare Medical earned clearance from the Food and Drug Administration for a new version of its Sonablate device. Sonablate, intended for use in the focused ablation of prostate ...

Transrectal ultrasound guided (TRUS) biopsy has been the gold standard for prostate cancer diagnosis, but carries a significant risk of urinary tract infection, sometimes requiring hospital admission ...

(WDBJ) - September is National Prostate Cancer Awareness month. One in eight men will develop prostate cancer in their lifetimes, and 35,000 men will die this year from it. For many men, it’s a ...